Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

2011792 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 379, Issue 9810, pp. 39-46

Field-Weighted Citation Impact: 44.47